JPS6140282A - N‐イミダゾリル誘導体およびそれらの製造方法 - Google Patents
N‐イミダゾリル誘導体およびそれらの製造方法Info
- Publication number
- JPS6140282A JPS6140282A JP15528985A JP15528985A JPS6140282A JP S6140282 A JPS6140282 A JP S6140282A JP 15528985 A JP15528985 A JP 15528985A JP 15528985 A JP15528985 A JP 15528985A JP S6140282 A JPS6140282 A JP S6140282A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- imidazolyl
- dihydro
- benzothiopyran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08418220A GB2161801B (en) | 1984-07-17 | 1984-07-17 | N-imidazolyl derivatives and process for their preparation |
| GB8418220 | 1984-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS6140282A true JPS6140282A (ja) | 1986-02-26 |
Family
ID=10564020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15528985A Pending JPS6140282A (ja) | 1984-07-17 | 1985-07-16 | N‐イミダゾリル誘導体およびそれらの製造方法 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS6140282A (fr) |
| BE (1) | BE902911A (fr) |
| DE (1) | DE3519432A1 (fr) |
| GB (1) | GB2161801B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984627B1 (en) | 1993-06-03 | 2006-01-10 | Astrazeneca Ab | Peptide derivatives |
| SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
-
1984
- 1984-07-17 GB GB08418220A patent/GB2161801B/en not_active Expired
-
1985
- 1985-05-30 DE DE19853519432 patent/DE3519432A1/de not_active Withdrawn
- 1985-07-16 BE BE0/215362A patent/BE902911A/fr not_active IP Right Cessation
- 1985-07-16 JP JP15528985A patent/JPS6140282A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB8418220D0 (en) | 1984-08-22 |
| BE902911A (fr) | 1986-01-16 |
| GB2161801B (en) | 1987-10-07 |
| DE3519432A1 (de) | 1986-01-23 |
| GB2161801A (en) | 1986-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4510149A (en) | N-Imidazolyl derivatives containing naphthalene or indene nucleus | |
| US4636500A (en) | N-(phenoxyalkyl)imidazoles as selective inhibitors of the thromboxane synthetase enzyme and pharmaceutical compositions thereof | |
| FI73969C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva trans-4-aminometylcyklohexankarboxylsyraderivat. | |
| EP0035863B1 (fr) | Dérivés d'imidazole, procédé pour leur préparation et leurs compositions pharmaceutiques | |
| US5204364A (en) | N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds | |
| RU2057748C1 (ru) | Способ получения производных гидразона или их солей неорганических кислот | |
| GB1559977A (en) | Amines | |
| GB2122997A (en) | Imidazoles | |
| RU2034834C1 (ru) | (4-амино-2,6-диметилфенилсульфонил)нитрометан, (4-ацетамидо-2,6-диметилфенилсульфонил)нитрометан и фармацевтическая композиция, обладающая свойствами ингибитора фермента альдозоредуктазы | |
| HUT61730A (en) | Process for producing 2-(imidazol-1-yl)-2-benzylethylidene aminoxy alkanecarboxylic acid derivatives and pharmaceutical compositions comprising same | |
| US4562199A (en) | Imidazole derivatives, compositions and use | |
| US6433021B1 (en) | Indane compounds and their pharmaceutical use | |
| HU226954B1 (en) | Process for producing hydrazonic acids and pharmaceutical composition containing them | |
| EP0106060B1 (fr) | Dérivés et sels d'imidazole, leur préparation et leurs formulations pharmaceutiques | |
| GB2141705A (en) | Imidazoles | |
| GB2161801A (en) | N-Imidazolyl derivatives and process for their preparation | |
| JPS6016975A (ja) | 双環性化合物のn−イミダゾリル誘導体およびそれらの製造法 | |
| WO1992011240A1 (fr) | Derives pyridyles de composes bicycliques substitues, et procede de preparation | |
| JPS63104964A (ja) | 強心剤4−エチル−1,3−ジヒドロ−5−〔4−(2−メチル−1h−イミダゾール−1−イル)ベンゾイル〕−2h−イミダゾール−2−オンのプロドラッグ誘導体 | |
| US4259343A (en) | Oxazole carbamates, formulations and asthma treatment | |
| GB2126218A (en) | Imidazoles | |
| PL137185B1 (en) | Method of obtaining novel derivatives of cis-bicyclo/3.3.0/octane | |
| JPS61100575A (ja) | チアゾ−ル誘導体 | |
| JPH07165573A (ja) | 抗血栓薬 | |
| EP0066254A1 (fr) | Mercaptoaminoacides, procédé de leur préparation et compositions pharmaceutiques les contenant |